Dr. Reddy's Laboratories
160 hedge funds and large institutions have $1.13B invested in Dr. Reddy's Laboratories in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 37 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 47
2.55% less ownership
Funds ownership: 57.54% → 54.99% (-2.6%)
8% less funds holding
Funds holding: 174 → 160 (-14)
17% less capital invested
Capital invested by funds: $1.37B → $1.13B (-$236M)
32% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 37
61% less call options, than puts
Call options by funds: $613K | Put options by funds: $1.58M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$36.6M |
| 2 |
BlackRock
New York
|
+$33.1M |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$17M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$11.9M |
| 5 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
+$7.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$27.6M |
| 2 |
Lazard Asset Management
New York
|
-$13.9M |
| 3 |
Renaissance Technologies
New York
|
-$13.8M |
| 4 |
AI
Axiom Investors
Greenwich,
Connecticut
|
-$13.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$12M |
RDY Hedge Fund Activity: Q1 2021 in Review
160 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2021, worth a combined $1.13B — down 17% from $1.37B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of RDY and 25 opened new positions — a net loss of 12 holders — while 47 trimmed existing stakes and 55 added.
The largest buyer was Morgan Stanley, adding an estimated $36.6M. The largest seller was Goldman Sachs, cutting an estimated $27.6M.
- 160 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2021, down from 174 in Q4 2020.
- Funds reported $1.13B of Dr. Reddy's Laboratories stock for Q1 2021, down 17% quarter-over-quarter.
- 25 funds opened new Dr. Reddy's Laboratories positions in Q1 2021 and 37 closed out, a net change of -12 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2021 was Morgan Stanley, an estimated $36.6M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2021 was Goldman Sachs, an estimated $27.6M sold.
Based on aggregated 13F filings for Q1 2021.